Hhlr Advisors, Ltd. Cure Vac N.V. Transaction History

Hhlr Advisors, Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$79.79 - $126.29 $4.09 Million - $6.47 Million	-51,199 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$46.76 - $136.27 $6.31 Million - $18.4 Million	-134,984 Reduced 72.5%	51,199 $4.15 Million
Q3 2020 Nov 16, 2020	BUY	$43.8 - $77.2 $8.15 Million - $14.4 Million	186,183 New	186,183 $8.67 Million

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $716M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Hhlr Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Hhlr Advisors, Ltd. with notifications on news.